DM Intelligence
DM Intelligence is a Guangzhou-based artificial intelligence development company specializing in AI solutions for small molecule drug discovery. Their proprietary platform, AI Drug Discovery Platform (AI-DDP), integrates AI technologies to optimize lead compounds with specific desired properties and design small molecules targeting specific sites or receptors. The platform analyzes and predicts physicochemical, biological, and toxicological properties of candidate drugs, aiming to improve drug discovery success rates and reduce R&D costs. The company serves pharmaceutical companies, academic centers, and biotech firms, leveraging a team of biomedical experts, chemists, AI engineers, and medical advisors. They have raised approximately ￥10 million CNY ($1.5M USD) in angel funding and actively participate in industry conferences such as AACR.
DM Intelligence
DM Intelligence is a Guangzhou-based artificial intelligence development company specializing in AI solutions for small molecule drug discovery. Their proprietary platform, AI Drug Discovery Platform (AI-DDP), integrates AI technologies to optimize lead compounds with specific desired properties and design small molecules targeting specific sites or receptors. The platform analyzes and predicts physicochemical, biological, and toxicological properties of candidate drugs, aiming to improve drug discovery success rates and reduce R&D costs. The company serves pharmaceutical companies, academic centers, and biotech firms, leveraging a team of biomedical experts, chemists, AI engineers, and medical advisors. They have raised approximately ￥10 million CNY ($1.5M USD) in angel funding and actively participate in industry conferences such as AACR.